CD8A and melanoma: The research further found that the transcription factor 7 (TCF7) is selectively expressed in memory-like T cells, so the ratio of CD8+TCF7+ to CD8+TCF7-TILs is strongly correlated with improved response and survival in melanoma patients treated with anti-PD-1 [84].